Viatris Inc (VTRS)
$16.38+1.93%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Cheap generics platform with real cash flow; waiting on plant clearance and pipeline readouts to re-rate.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Viatris Inc
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater Chi…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - Specialty & Generic
- Market Cap:
- $18.3B
Recent dividends
- 22 May 2026$0.12
- 9 Mar 2026$0.12
- 24 Nov 2025$0.12
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Viatris Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free